Skip to content

Study · Randomized controlled trial · 2015

1 result

Vasopressin, but not oxytocin, increases empathic concern among individuals who received higher levels of paternal warmth: A randomized controlled trial.

Tabak BA, Meyer ML, Castle E, Dutcher JM, Irwin MR, Han JH, Lieberman MD, Eisenberger NI

Psychoneuroendocrinology17 Oct 2014Cited by 46 (Europe PMC)

PMID25462898 (opens in a new tab)PMCIDPMC4268337 (opens in a new tab)DOI10.1016/j.psyneuen.2014.10.006 (opens in a new tab)PepBankPUB-25462898
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In a randomized placebo-controlled study, oxytocin had no main or interaction effects on empathic responding, including with parental warmth.

    In plain wordsIn a trial in people, oxytocin did not change empathy compared with placebo, including in people who reported high parental warmth.

    Peptide
    Oxytocin
    Outcome
    No significant changeEmpathic concern ratings
    Study

    n: not reported in source

    Comparator
    Placebo
    Outcome group
    Social behavior and cognition · Mental health and mood
    Studied dose
    Dose not stated

    Source sentences

    Summary
    No main or interaction effects were found for individuals who received oxytocin.
    1 context sentence
    Summary · context
    We investigated how vasopressin and oxytocin affect empathic responding in a randomized, double-blind, placebo controlled, between-subjects study design.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Registered trials1

Trials this study reports on, or that list this study as a reference. Registry data from ClinicalTrials.gov.

1 trial · 1 completed · source ClinicalTrials.gov (opens in a new tab)

CompletedEarly phase 1NCT01680718

Neuropeptides and Social Behavior

University of California, Los Angelesn = 160Oct 2012 to Sept 2013

Social Psychology

Trial pageClinicalTrials.govUpdated 28 May 2015

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 01:30 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:49 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.